Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deproteinised Calf Blood Serum Injection for Acute Intracerebral Hemorrhage
NCT03260153Unknown
- Sponsor
- Beijing Tiantan Hospital
- Start
- Jan 2017
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Randomised, double-blind trial of deproteinized calf blood extract in intracerebral hemorrhage (ICH) (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoints: Changes of cytotoxic and vasogenic edema at 3 days, Changes of vasogenic edema at 14 days and 1 more. Status: unknown.
02
Drugs
deproteinized calf blood extract
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT03260153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03260153.